Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | PTPN2 | P17706 | 2/20 | 0.31 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | APEX1 | P27695 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14458137 | 1.00 | ALDH1A1 (0.33) | ALDH1A1KMT2AMAPTHPGDTSHR | |
| SCHEMBL5606210 | 1.00 | ALDH1A1 (0.33) | ALDH1A1KMT2AMAPTHPGDTSHR | |
| SCHEMBL9591636 | 0.78 | KDM4E (0.32) | KMT2ALMNAKDM4EGAAMEN1 | |
| SCHEMBL9001209 | 0.77 | ALDH1A1 (0.31) | ALDH1A1KMT2ATSHRMEN1 | |
| SCHEMBL19649525 | 0.77 | ALDH1A1 (0.34) | ALDH1A1KMT2AMAPTHPGDTSHR | |
| SCHEMBL14458046 | 0.77 | ALDH1A1 (0.34) | ALDH1A1KMT2AMAPTHPGDTSHR | |
| SCHEMBL11177204 | 0.75 | CCNA2 (0.34) | ALDH1A1KMT2AMAPTHPGDTSHR | |
| SCHEMBL5605691 | 0.75 | ALDH1A1 (0.32) | ALDH1A1KMT2AHIF1ALMNAMEN1 | |
| SCHEMBL1713453 | 0.75 | ALDH1A1 (0.33) | ALDH1A1KMT2AMAPTHPGDTSHR | |
| SCHEMBL10651665 | 0.75 | ALDH1A1 (0.33) | ALDH1A1KMT2AMAPTHPGDTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115918653-A | Cyclohexenone safener and application thereof, and weeding composition and application thereof | 东北农业大学 | 2023-04-07 | — | — | CN | claimed |
| CN-114044735-A | Method for synthesizing tetra-acetal | 万华化学集团股份有限公司 | 2022-02-15 | — | — | CN | claimed |
| WO-2020109533-A1 | PROCESS FOR SELECTIVE SYNTHESIS OF 4-HYDROXYISOPHORONE AND 4-KETOISOPHORONE BY FUNGAL PEROXYGENASES | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS (CSIC) (ES) | 2020-06-04 | — | — | WO | claimed |
| EP-3660147-A1 | PROCESS FOR SELECTIVE SYNTHESIS OF 4-HYDROXYISOPHORONE AND 4-KETOISOPHORONE BY FUNGAL PEROXYGENASES | Consejo Superior de Investigaciones Cientificas (CSIC) (ES) | 2020-06-03 | — | — | EP | claimed |
| EP-1284950-A1 | PROCESS FOR THE PRODUCTION OF 2,2,6-TRIMETHYLCYCLOHEXANE-1,4-DIONE | Degussa AG (DE) | 2003-02-26 | — | — | EP | claimed |
| US-20020165414-A1 | Process for the production of 2,2,6-trimethylcyclohexane-1, 4-dione | KRILL STEFFEN (DE) | 2002-11-07 | — | — | US | claimed |
| US-6420609-B2 | EPOXIDATION OF ISOPHORONE WITH PERCARBOXYLIC ACID | DEGUSSA AG (DE) | 2002-07-16 | — | — | US | claimed |
| US-20020010305-A1 | Process for the production of 2,2,6-trimethylcyclohexane-1,4-dione | DEGUSSA AG (DE) | 2002-01-24 | — | — | US | claimed |
| WO-2001087811-A1 | PROCESS FOR THE PRODUCTION OF 2,2,6-TRIMETHYLCYCLOHEXANE-1,4-DIONE | DEGUSSA AG (DE) | 2001-11-22 | — | — | WO | claimed |
| US-4898984-A | OXIDATION OF BETA-ISOPHORONE IN HYDROGEN PEROXIDE AND FORMIC ACID SOLUTION | HUELS AKTIENGESELLSCHAFT (DE) | 1990-02-06 | — | — | US | claimed |
| EP-0330745-A2 | Process for the preparation of 3,5,5-trimethyl-4-hydroxy-2-cyclohexen-1-one | HÜLS AKTIENGESELLSCHAFT (DE) | 1989-09-06 | — | — | EP | claimed |
| US-3989857-A | Flavoring phenol or phenol derivative containing food or feed with cycloaliphatic derivatives | FIRMENICH S.A. (CH) | 1976-11-02 | — | — | US | claimed |
| US-12618050-B2 | Engineered polypeptides that exhibit increased catalytic efficiency for unnatural cofactors and uses thereof | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2026-05-05 | — | — | US | disclosed |
| WO-2025224076-A1 | SUBSTITUTED ARYLPYRAZINES AND SALTS THEREOF, AND USE THEREOF AS HERBICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2025-10-30 | — | — | WO | disclosed |
| CN-115918653-A | Cyclohexenone safener and application thereof, and weeding composition and application thereof | 东北农业大学 | 2023-04-07 | — | — | CN | disclosed |
| WO-2022127774-A1 | PYRIDINE DERIVATIVE AND USE THEREOF IN MEDICINE | 成都百裕制药股份有限公司 | 2022-06-23 | — | — | WO | disclosed |
| US-3983885-A | AROMATIC COMPOSITIONS | FIRMENICH S.A. (CH) | 1976-10-05 | — | — | US | disclosed |
| US-3981311-A | Aromatic compositions | FIRMENICH S.A. (CH) | 1976-09-21 | — | — | US | disclosed |
| US-3957061-A | Aromatic compositions | FIRMENICH S.A. (CH) | 1976-05-18 | — | — | US | disclosed |
| US-3937228-A | Aromatic compositions | FIRMENICH SA (CH) | 1976-02-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12618050-B2 | Engineered polypeptides that exhibit increased catalytic efficiency for unnatural cofactors and uses thereof | NNMT, NAPRT, NQO1 | ALDH1A1 754/4885KMT2A 359/4885MAPT 4019/4885 |
| US-20020165414-A1 | Process for the production of 2,2,6-trimethylcyclohexane-1, 4-dione | HPD, OXER1, DHPS | ALDH1A1 869/4885KMT2A 3841/4885MAPT 3735/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.